Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC

BSE7817.70-35.05 (-0.45 %)

PREV CLOSE ( ) 7852.75

OPEN PRICE ( ) 7852.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 466

TODAY'S LOW / HIGH ( )7700.00 7860.50

52 WK LOW / HIGH ( )6501.6 10653.05

NSE7827.50-24.5 (-0.31 %)

PREV CLOSE( ) 7852.00

OPEN PRICE ( ) 7790.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 7827.50 (150)

VOLUME 7311

TODAY'S LOW / HIGH( ) 7700.00 7877.00

52 WK LOW / HIGH ( )7201.15 10691

Chairman	Shilpa Divekar Nirula
Company Secretary	Tanya Sanish
Executive Director	Praveen Rao Akkinepally
Non Executive Director	Hooi-Bien Chuah
Non Executive Independent Director	Revathy Ashok Monica Widhani
Whole Time Director	Bhavana Agrawal

Incorporation Year : 11-07 1979

Registered Office :

Address : Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road Bengaluru,
Karnataka-560045 .

Phone : 080 6774 8000

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE